~~<i id='AF4A98FA65'><strike id='AF4A98FA65'><tt id='AF4A98FA65'><pre id='AF4A98FA65'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：hotspot 2025-09-07 21:56:13 - browse：4941

Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： White House touts steps to stem shortages of cancer treatments

explore

focus

entertainment

leisure time

hotspot

knowledge

AdobeThistimelastyear,membersofCongresswereworkingaroundtheclocktodraftandpasstheInflationReductionA

WSS

Statins may not be needed by millions of people, study suggests

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

A common UTI test for kids haunts adults as a traumatic 'nightmare'

STAT Virtual Event: ASCO Recap, Live!

PEPFAR is under serious threat — and so is global health

focus

leisure time

explore

Duchenne breakthrough therapy leaves behind pioneering families

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Medicare details structure of new drug price negotiation program

How faith leaders like me can help address America's obesity epidemic

What does generative AI mean for health care? We asked experts

Readers discuss the intersection of pregnancy and addiction

Peter Hotez and the public health issue of online harassment

NIH tests clinical research in primary care with $30 million program

Drug repurposing or repositioning? The language matters

'Essentially witchcraft:' A former naturopath takes on the field

focus

Statins may not be needed by millions of people, study suggests

Regeneron agrees to White House price limits on anti

Private equity could exacerbate cardiology's overuse problem, experts fear

Coercive sterilizations revealed by STAT prompt outrage

PEPFAR is under serious threat — and so is global health

STAT Virtual Event: ASCO Recap, Live!

entertainment

leisure time

hotspot

knowledge